Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal Granisetron for Gastroparesis
NCT04501211Phase 2Withdrawn
- Sponsor
- Indiana University
- Start
- Jan 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Granisetron Hydrochloride Nasal Spray in gastroparesis, sponsored by Indiana University. Planned start Jan 2019; status: withdrawn.
02
Drugs
Granisetron Hydrochloride Nasal Spray
03
Conditions
gastroparesis
Beyond the preview
Go deeper on NCT04501211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04501211.